Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Brain Res ; 409: 113307, 2021 07 09.
Article in English | MEDLINE | ID: mdl-33872664

ABSTRACT

BACKGROUND: Although Amyloid beta (Aß) and N - methyl d- aspartate receptors (NMDARs are involved in Ca2+ neurotoxicity, the function of mitochondrial calcium uniporter in cognition deficit remain uncertain. Here, we examined the effect of mitochondrial calcium uniporter (MCU) blocker, together with NMDA receptor agonist d-cycloserine (DCS) on memory impairment in a rat model of AD. METHODS: Forty adult male Wistar rats underwent stereotaxic cannulation for inducing AD by intracerebroventricular (ICV) injection of Aß1-42 (5 µg /8 µl/rat). Then animals were divided into 5 groups of: Saline + Saline, Aß + Saline, Aß + RU360, Aß + DCS, Aß + RU360 + DCS. Two weeks after the treatments, Morris Water Maze (MWM) and step through passive avoidance learning (SPL) were undertaken for evaluating of spatial and associative memories, respectively. Hippocampal level of cyclic-AMP response element binding protein (CREB) and brain-derived neurotrophic factor (BDNF) were measured by western blot and ELISA. RESULTS: Co - administration of RU360 and DCS significantly improved both acquisition and retrieval of spatial memory as evident by decreased escape latency and increased time spent in the target quadrant (TTS) in MWM, together with increase in step-through latency, but reduced time spent in the dark compartment in SPL. Furthermore, there was a significant rise in the hippocampal level of CREB and BDNF in comparison with Aß + Saline. CONCLUSION: The present study supports the idea that co- administration of RU360 and DCS ameliorate memory impairment induced by Aß 1-42 probably via CREB / BDNF signaling.


Subject(s)
Alzheimer Disease/drug therapy , Amyloid beta-Peptides/pharmacology , Antimetabolites/pharmacology , Calcium Channels/drug effects , Cycloserine/pharmacology , Excitatory Amino Acid Agonists/pharmacology , Hippocampus/drug effects , Memory Disorders/drug therapy , Peptide Fragments/pharmacology , Ruthenium Compounds/pharmacology , Animals , Behavior, Animal/drug effects , Brain-Derived Neurotrophic Factor/drug effects , CREB-Binding Protein/drug effects , Disease Models, Animal , Drug Synergism , Drug Therapy, Combination , Male , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/agonists
SELECTION OF CITATIONS
SEARCH DETAIL
...